Skip to main content

Table 4 Levels of circulating miRNAs in patients with diabetes receiving aspirin, clopidogrel or prasugrel. Values shown are mean ± SD. P values were generated by one-way repeated measures ANOVA with Greenhouse–Geisser correction

From: Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

miR2−(ΔΔCq) (mean ± SD)pPartial η2 (effect size)
AspirinClopidogrelPrasugrel
211.21 ± 0.671.04 ± 0.511.03 ± 0.470.0280.065
241.05 ± 0.640.88 ± 0.700.75 ± 0.400.0090.084
27b1.09 ± 0.790.96 ± 1.220.75 ± 0.380.1150.042
280.83 ± 0.540.65 ± 0.530.63 ± 0.600.0830.046
931.06 ± 0.600.95 ± 0.741.01 ± 0.780.6620.007
1220.93 ± 0.820.98 ± 0.981.07 ± 1.000.2780.023
1260.93 ± 0.420.83 ± 0.470.80 ± 0.340.1100.057
1500.83 ± 0.340.81 ± 0.430.80 ± 0.360.7770.004
1910.87 ± 0.650.66 ± 0.620.59 ± 0.480.0170.073
1971.13 ± 0.680.97 ± 0.820.82 ± 0.450.0190.072
2230.93 ± 0.550.78 ± 0.500.70 ± 0.410.0140.076
3200.93 ± 0.460.82 ± 0.460.79 ± 0.400.0870.045
451a1.04 ± 0.650.95 ± 0.431.20 ± 0.990.1650.034
4860.96 ± 0.700.85 ± 0.451.11 ± 1.170.2150.028